Kindred Biosciences reported $3.54M in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Adma Biologics ADMA:US $ 20.68M 2.85M
Bayer BAYN:GR € 9781M 1073M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Dynavax Technologies DVAX:US $ 108.27M 55.5M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Idexx Laboratories IDXX:US $ 810.42M 15.72M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Kindred Biosciences KIN:US $ 3.54M 1.14M
Merk MRK:US $ 13154M 1752M
Minerva Neurosciences NERV:US $ 0 0
Novavax NVAX:US $ 178.84M 119.17M
Phibro Animal Health PAHC:US $ 214.66M 5.61M
Zoetis ZTS:US $ 1990M 42M